Adjuvant therapy for HER2 positive breast cancer: Are anthracyclines still necessary?

Aurelio B. Castrellon, Stefan Glück

Research output: Contribution to journalArticle

3 Scopus citations

Fingerprint Dive into the research topics of 'Adjuvant therapy for HER2 positive breast cancer: Are anthracyclines still necessary?'. Together they form a unique fingerprint.

Medicine & Life Sciences